Abstract
Rapid advances of genomic technologies in medical sciences resulted in growth of identified molecular biomarkers, including those required for proper drug administration and therapy selection in pulmonary diseases. While high-throughput technologies are powerful tool for wide screening, targeted real-time monitoring using nucleic acid amplification is still the most important method for DNA and RNA detection widely employed in clinical diagnostics. In this chapter, we overview the key nucleic acid amplification platforms successfully used in the clinical diagnostics, including that associated with pulmonary diseases, and briefly outline their advantages and pitfalls. We further focus on the specific isothermal amplification technology SmartAmp and Eprobes developed by RIKEN outlining its implementation in quick and robust detection of several clinically important SNP and cancer-associated somatic mutations. Finally, we describe the further potential of expansion of utilization of Eprobes platform for direct protein detection for clinical diagnostic needs.
Keywords
- Nucleic acid amplification
- Clinical diagnostics
- Companion diagnostics
This is a preview of subscription content, access via your institution.
Buying options




References
Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.
Lele RD. The human genome project: its implications in clinical medicine. J Assoc Physicians India. 2003;51:373–80.
Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J, et al. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res. 2017;45(D1):D777–D83.
Craw P, Balachandran W. Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review. Lab Chip. 2012;12(14):2469–86.
Spargo CA, Fraiser MS, VanCleve M, Wright DJ, Nycz CM, Spears PA, et al. Detection of M-tuberculosis DNA using thermophilic strand displacement amplification. Mol Cell Probes. 1996;10(4):247–56.
Compton J. Nucleic acid sequence-based amplification. Nature. 1991;350(6313):91–2.
Vincent M, Xu Y, Kong H. Helicase-dependent isothermal DNA amplification. EMBO Rep. 2004;5(8):795–800.
Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28(12)
Piepenburg O, Williams CH, Stemple DL, Armes NADNA. Detection using recombination proteins. PLoS Biol. 2006;4(7):1115–21.
Mitani Y, Lezhava A, Kawai Y, Kikuchi T, Oguchi-Katayama A, Kogo Y, et al. Rapid SNP diagnostics using asymmetric isothermal amplification and a new mismatch-suppression technology. Nat Methods. 2007;4(3):257–62.
Mitani Y, Lezhava A, Sakurai A, Horikawa A, Nagakura M, Hayashizaki Y, et al. Rapid and cost-effective SNP detection method: application of SmartAmp2 to pharmacogenomics research. Pharmacogenomics. 2009;10(7):1187–97.
Chang HS, Mizukami K, Yabuki A, Hossain MA, Rahman MM, Uddin MM, et al. A novel rapid genotyping technique for collie eye anomaly: SYBR green-based real-time polymerase chain reaction method applicable to blood and saliva specimens on flinders technology associates filter paper. J Vet Diagn Investig. 2010;22(5):708–15.
Elenitoba-Johnson KSJ, Bohling SD, Wittwer CT, King TC. Multiplex PCR by multicolor fluorimetry and fluorescence melting curve analysis. Nat Med. 2001;7(2):249–53.
Juskowiak B. Nucleic acid-based fluorescent probes and their analytical potential. Anal Bioanal Chem. 2011;399(9):3157–76.
Arikawa E, Sun Y, Wang J, Zhou Q, Ning B, Dial SL, et al. Cross-platform comparison of SYBR green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray quality control (MAQC) study. BMC Genomics. 2008;9:328.
Tyagi S, Kramer FR. Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol. 1996;14(3):303–8.
Tapp I, Malmberg L, Rennel E, Wik M, Syvanen AC. Homogeneous scoring of single-nucleotide polymorphisms: comparison of the 5 '-nuclease TaqMan (R) assay and molecular beacon probes (vol 28, pg 732, 2000). BioTechniques. 2000;29(3):546.
Whitcombe D, Kelly S, Mann J, Theaker J, Jones C, Little S. Scorpions (TM) primers - a novel method for use in single-tube genotyping. Am J Hum Genet. 1999;65(4):A412.
Okamoto A. ECHO probes: a concept of fluorescence control for practical nucleic acid sensing. Chem Soc Rev. 2011;40(12):5815–28.
Hanami T, Delobel D, Kanamori H, Tanaka Y, Kimura Y, Nakasone A, et al. Eprobe mediated real-time PCR monitoring and melting curve analysis. PLoS One. 2013;8(8)
Kimura Y, Hanami T, Tanaka Y, de Hoon MJL, Soma T, Harbers M, et al. Effect of thiazole orange doubly labeled thymidine on DNA duplex formation. Biochemistry. 2012;51(31):6056–67.
Murdock DG, Wallace DC. PNA-mediated PCR clamping. Applications and methods. Methods Mol Biol. 2002;208:145–64.
Efrati E, Elkin H, Peerless Y, Sabo E, Ben-Izhak O, Hershkovitz D, LNA-based PCR. Clamping enrichment assay for the identification of KRAS mutations. Cancer Biomark. 2010;8(2):89–94.
Atsumi J, Hanami T, Enokida Y, Ogawa H, Delobel D, Mitani Y, et al. Eprobe-mediated screening system for somatic mutations in the KRAS locus. Oncol Rep. 2015;33(6):2719–27.
Mitri Z, Constantine T, O'Regan R. The HER2 receptor in breast cancer: pathophysiology, clinical use, and new advances in therapy. Chemother Res Pract. 2012;2012:743193.
Arcila ME, Chaft JE, Nafa K, Roy-Chowdhuri S, Lau C, Zaidinski M, et al. Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas. Clin Cancer Res. 2012;18(18):4910–8.
Mazieres J, Peters S, Lepage B, Cortot AB, Barlesi F, Beau-Faller M, et al. Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives. J Clin Oncol. 2013;31(16):1997–U307.
Takase Y, Usui K, Shimizu K, Kimura Y, Ichihara T, Ohkawa T, et al. Highly sensitive detection of a HER2 12-base pair duplicated insertion mutation in lung cancer using the Eprobe-PCR method. PLoS One. 2017;12(2):e0171225.
Enokida Y, Shimizu K, Atsumi J, Lezhava A, Tanaka Y, Kimura Y, et al. Rapid detection of SNP (c.309T > G) in the MDM2 gene by the duplex SmartAmp method. PLoS One. 2013;8(4)
Bayer PM, Fabian B, Hubl W. Immunofluorescence assays (IFA) and enzyme-linked immunosorbent assays (ELISA) in autoimmune disease diagnostics - technique, benefits, limitations and applications. Scand J Clin Lab Invest Suppl. 2001;61:68–76.
Soderberg O. Detection of proteins and their interactions by proximity-ligation. Chromosom Res. 2007;15:2–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Gusev, O., Hayashizaki, Y., Usui, K. (2018). Nucleic Acid Amplification-Based Diagnostics for Pulmonary Diseases: What Is the Current State and Perspectives of Nucleic Acid Amplification Technologies Used in Diagnostics Associated with Pulmonary Diseases?. In: Kaneko, T. (eds) Clinical Relevance of Genetic Factors in Pulmonary Diseases. Respiratory Disease Series: Diagnostic Tools and Disease Managements. Springer, Singapore. https://doi.org/10.1007/978-981-10-8144-6_18
Download citation
DOI: https://doi.org/10.1007/978-981-10-8144-6_18
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-8143-9
Online ISBN: 978-981-10-8144-6
eBook Packages: MedicineMedicine (R0)